Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (41-50 of 300) with videos related to

Pageof 30
Sort By:
Future Oncology (London, England)|January 15, 2021
Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomasPatrick M Reagan, Jonathan W Friedberg
Seminars in Hematology|April 3, 2008
Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Introduction to Genomics in Hematologic MalignancyBenjamin L Ebert, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to H.J.A. Adams et al and E.A. Hawkes et alOliver W Press, Jonathan W Friedberg
Expert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I Fisher
Current Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S Freedman
Hematology/Oncology Clinics of North America|August 31, 2020
Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell LymphomaThomas D Rodgers, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)|May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New DirectionsPatrick M Reagan, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2022
<i>JCO</i> Turns 40Kathy D Miller, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young AdultsKara M Kelly, Jonathan W Friedberg
Pageof 30

Showing results (41-50 of 300) with videos related to

Sort By:
Pageof 30
Future Oncology (London, England)|January 15, 2021
Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomasPatrick M Reagan, Jonathan W Friedberg
Seminars in Hematology|April 3, 2008
Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Introduction to Genomics in Hematologic MalignancyBenjamin L Ebert, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to H.J.A. Adams et al and E.A. Hawkes et alOliver W Press, Jonathan W Friedberg
Expert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I Fisher
Current Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S Freedman
Hematology/Oncology Clinics of North America|August 31, 2020
Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell LymphomaThomas D Rodgers, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)|May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New DirectionsPatrick M Reagan, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2022
<i>JCO</i> Turns 40Kathy D Miller, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young AdultsKara M Kelly, Jonathan W Friedberg
Pageof 30